Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: Non-linear time series analysis

BMJ Open

Volumn 5, Issue 3, 2015, Pages

  Lawes, Timothy ^a   López Lozano, José María ^b   Nebot, César ^c   Macartney, Gillian ^d   Subbarao Sharma, Rashmi ^d   Dare, Ceri R J ^d   Edwards, Giles F S ^e   Gould, Ian M ^d  

^a ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

^b HOSPITAL VEGA BAJA   (Spain)

^c Centro Universitario de la Defensa de San Javier   (Spain)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^e Scottish MRSA Reference Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; HAND WASHING; HOSPITAL; HOSPITAL BED UTILIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PHENOTYPE; POPULATION STRUCTURE; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; UNITED KINGDOM; ADULT; BACTERIUM IDENTIFICATION; CLASSIFICATION; CROSS INFECTION; DRUG RESISTANCE; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; SPECIES DIFFERENCE; STAPHYLOCOCCAL INFECTIONS;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE; HAND HYGIENE; HUMANS; INFECTION CONTROL; LENGTH OF STAY; MACROLIDES; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PREVALENCE; RETROSPECTIVE STUDIES; SCOTLAND; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 84926451385     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006596     Document Type: Article

References (55)

1. Wertheim HFL, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62.
2. Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet 1963;1:904-7.
3. WHO. Antimicrobial resistance: Global Report on Surveillance 2014. Geneva, Switzerland. World Health Organisation, 2014. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf?ua=1 (accessed 3 Sep 2014).
4. Hartman B, Tomasz A. Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 1981;19:726-35.
5. Deresinski S. Methicillin-resistant staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005;40:562-73.
6. Noto MJ, Kreiswirth BN, Monk AB, et al. Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus. J Bacteriol 2008;190:1276-83.
7. Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010;10:227-39.
8. Popovich K, Hota B, Rice T, et al. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:2293-5.
9. Kouyos R, Klein E, Grenfell B. Hospital-community interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus. PLoS Pathog 2013;9:e1003134.
10. Kardas-Sloma L, Boëlle PY, Opatowski L, et al. Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrob Agents Chemother 2011;55:4888-95.
11. Kardas-Sloma L, Boelle PY, Opatowski L, et al. Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2013;57:4410-16.
12. Stone SP, Fuller C, Savage J, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 2012;344:e3005.
13. Nathwani D, Sneddon J, Malcolm W, et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 2011;38:16-26.
14. Dixon J, Duncan CJ. Importance of antimicrobial stewardship to the English National Health Service. Infect Drug Resist 2014;7:145-52.
15. Thouverez M, Muller A, Hocquet D, et al. Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital. J Med Microbiol 2003;52:801-6.
16. Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J Antimicrob Chemother 2011;66:2685-8.
17. Wyllie DH, Walker AS, Miller R, et al. Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open 2011;1:e000160.
18. McAdam PR, Templeton KE, Edwards GF, et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2012;109:9107-12.
19. Donnio PY, Preney L, Gautier-Lerestif AL, et al. Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11year period. J Antimicrob Chemother 2004;53:808-13.
20. Nielsen KL, Pedersen TM, Udekwu KI, et al. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J Antimicrob Chemother 2012;67:1325-32.
21. Horváth A, Dobay O, Kardos S, et al. Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2012;31:2029-36.
22. Knight GM, Budd EL, Whitney L, et al. Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 2012;67:2514-22.
23. Holden MTG, Hsu LY, Kurt K, et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 2013;23:653-64.
24. López-Lozano JM, Monnet DL, Yagüe A, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000;14:21-31.
25. Lawes T, Edwards B, López-Lozano JM, et al. Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis. BMJ Open 2012;2:e000797.
26. Aldeyab MA, Monnet DL, López-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593-600.
27. Kaier K, Hagist C, Frank U, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:346-53.
28. Bertrand X, Lopez-Lozano JM, Slekovec C, et al. Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA. J Hosp Infect 2012;82:164-9.
29. MacKenzie FM, Lopez-Lozano JM, Monnet DL, et al. Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: a time-series analysis. J Hosp Infect 2007;67:225-31.
30. Levy SB. Balancing the drug-resistance equation. Trends Microbiol 1994;2:341-2.
31. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci 1999;96:1152-6.
32. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007;59:833-40.
33. WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs, 2013. http://www.whocc.no/atc-ddd-publications/atc-ddd-index/ (accessed 3 Sep 2014).
34. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
35. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis 2008;8:427-34.
36. Reilly JS, Stewart S, Christie P, et al. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect 2010;74:35-41.
37. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 2004;56:10-15.
38. McVicker G, Prajsnar TK, Williams A, et al. Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention. PLoS Pathog 2014;10:e1003959.
39. Pressley J, D'Agata EMC, Webb GF. The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion. J Theor Biol 2010;264:645-56.
40. Beggs CB, Shepherd SJ, Kerr KG. Increasing the frequency of hand washing by healthcare workers does not lead to commensurate reductions in staphylococcal infection in a hospital ward. BMC Infect Dis 2008;8:114.
41. Beggs CB, Shepherd SJ, Kerr KG. How does healthcare worker hand hygiene behaviour impact upon the transmission of MRSA between patients? An analysis using a Monte Carlo model. BMC Infect Dis 2009;9:64.
42. Borg MA, Suda D, Scicluna E. Time-series analysis of the impact of bed occupancy rates on the incidence of methicillin-resistant Staphylococcus aureus infection in overcrowded general wards. Infect Control Hosp Epidemiol 2008;29:496-502.
43. National Audit Office. Improving patient care by reducing the risk of hospital acquired infection: a progress report. London, UK: National Audit Office (NAO), 2009. http://www.nao.org.uk/report/improving-patient-care-by-reducing-the-risk-of-hospital-acquired-infection-a-rogress-report/ (accessed 3 Sep 2014).
44. Cunningham JB, Kernohan WG, Rush T. Bed occupancy, turnover intervals and MRSA rates in English hospitals. Br J Nurs Mark Allen Publ 2006;15:656-60.
45. Kraker MEA, de Wolkewitz M, Davey PG, et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011;55:1598-605.
46. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149-57.
47. Sangal V, Girvan EK, Jadhav S, et al. Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit in Scotland. Int J Antimicrob Agents 2012;40:323-31.
48. Otter JA, Patel A, Cliff PR, et al. Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme. J Antimicrob Chemother 2013;68:992-9.
49. Gurieva T, Bootsma MCJ, Bonten MJM. Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus. PLoS Comput Biol 2013;9: e1002874.
50. Otter JA, Herdman MT, Williams B, et al. Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs universal screening. J Hosp Infect 2013;83:114-21.
51. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 2000;97:1938-43.
52. Hunt AC, Edwards B, Girvan EK, et al. Methicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns. J Clin Microbiol 2011;49:1975-8.
53. Finch R. Current challenges in antimicrobial resistance and healthcare-associated infections: role and organization of ARHAI. J Antimicrob Chemother 2012;67(Suppl 1):i3-10.
54. Vidal PM, Trindade PA, Garcia TO, et al. Differences between 'classical' risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain. Infect Control Hosp Epidemiol 2009;30:139-45.
55. Nathwani D, Morgan M, Masterton RG, et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008;61:976-94.